Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 20 May 2016, 10:46 HKT/SGT
Share:
    

Source: Hitachi, Ltd.
Hokkaido University Hospital Begins Treatments of Extraordinary Precision as the World's First Facility Equipped with Both Real-Time Image Gated and Spot Scanning Proton Beam Therapy
Clinical Treatments Take Advantage of Both Gantry Mounted Cone Beam CT and Intensity Modulated Proton Therapy

TOKYO, May 20, 2016 - (JCN Newswire) - Hokkaido University and Hitachi, Ltd.(TSE:6501, "Hitachi") have jointly developed an advanced technique to treat moving targets with proton beam therapy. This project was awarded a grant in 2010 under the Funding Program for World-Leading Innovative R&D on Science and Technology (the "FIRST Program"), a national project sponsored by the Japanese government. This new technique is now being clinically used with two additional capabilities - Cone Beam CT ("CBCT") and Intensity Modulated Proton Therapy ("IMPT").

Proton beam therapy (PBT) is an advanced type of cancer radiotherapy. Protons, the atomic nuclei of hydrogen, are accelerated to high speed and their energy is concentrated onto tumors. The superb characteristics of proton beams allow patients to maintain their normal lifestyles during treatment as it is painless and impact to the body's normal functions are minimized. PBT has thus attracted attention as a cutting-edge therapy for treating cancer whilst maintaining patients' quality of life ("QOL"). As these characteristics enable precise dose concentration, PBT can be easily applied to stationary targets such as brain tumors. Treatment however, of tumors in the torso such as those in the lung or liver which move due to respiration, require special care - and thus the combination of PBT with real-time tracking to target moving tumors has been highly anticipated.

Hokkaido University Hospital began treating patients with Spot Scanning proton beam therapy in March of 2014 and by December of that year had begun treating patients with Real-Time image Gated Proton Beam Therapy ("RGPT"). Since then, RGPT has been used in approximately 40% of treatments involving the liver and prostate and 10% of those involving the lung and pancreas. Over 80% of all treatments at the hospital now incorporate RGPT.

1) Gantry Mounted CBCT

To further improve the accuracy of PBT, there is a constant need for improved imaging of the internal structure of the tumor region. When information on the location of bone is taken from traditional orthogonal x-rays and the motion of tumors is captured by RGPT and then combined with the ability to identify healthy tissue surrounding a tumor, particularly the location and shape of soft tissue, it allows for a greater therapeutic dose to be directed at the tumor while significantly reducing the risk of irradiating healthy tissue. As a result, the ability to obtain this information immediately prior to treatment is increasingly being recognized as critical.

The rotating gantry mounted CBCT system, jointly developed by Hokkaido University and Hitachi, provides three-dimensional anatomical images of patients, at isocenter immediately prior to being treated, dramatically increasing the precision of the treatments. The CBCT system is also capable of highly accurate positioning even without the use of RGPT. After being approved for marketing under Japan's Pharmaceutical Affairs Law in March of 2015, the system was clinically put to use in October of the same year. Since then, 20 patients have been treated with the CBCT-equipped system and more patients are expected to benefit as clinical treatments continue.

Hokkaido University Hospital and Hitachi will continue to work together on a project titled Development of Medical Devices and Systems for Advanced Medical Services funded by the Japan Agency for Medical Research and Development (AMED) to further advance RGPT.

2) Intensity Modulated Proton Therapy (IMPT)

Intensity Modulated Proton Therapy is a form of Spot Scanning proton therapy, where the energies of proton beams directed from various angles are manipulated so that tumors of complex shapes can be precisely irradiated while minimizing the effect of radiation to surrounding healthy tissues.

Hokkaido University Hospital has collaborated with Hitachi in optimizing its treatment planning system to work seamlessly with IMPT for moving targets. By combining robust optimization designed to address inherent challenges in particle therapy treatments such as range uncertainties and treatment planning setup uncertainties with the tight dose distribution achieved through IMPT, the impact of moving targets can be minimized.

In August 2015, clinical use of IMPT began and has since been used for prostate, liver head & neck, and pediatric treatments. Plans are underway to further increase the number of treatable tumor types in accordance to accepted guidelines.

This announcement will be made at the upcoming 55th Annual Particle Therapy Co-Operative Group Meeting (PTCOG55) held in Prague, Czech Republic from May 22-28.

Hokkaido University Hospital, with their experience in radiation therapy and Hitachi, with their expertise in engineering design have combined their respective strengths in medicine and technology to offer cutting edge technology for cancer patients within the growing global market of proton beam therapy. Both organizations are committed to continued research and development to improve the quality of life of cancer patients through advanced proton beam therapy.


Contact:
Hitachi Ltd
Corporate Communications
Tel: +81-3-3258-1111



Topic: Press release summary
Sectors: BioTech
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2021 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


Hitachi, Ltd. Links

http://www.hitachi.com

https://www.facebook.com/hitachi.global/

https://twitter.com/hitachiglobal?lang=en

https://www.youtube.com/user/HitachiBrandChannel

https://ph.linkedin.com/company/hitachi

Hitachi, Ltd.
Jan 12, 2021 11:21 HKT/SGT
Thailand's First Demonstration Project of Optimized Performance Enabling Network for Volt/Var(Q) (OPENVQ) in Power Transmission Networks
Jan 6, 2021 17:48 HKT/SGT
Olympus and Hitachi Announce Long-Term Business Alliance regarding Endoscopic Ultrasound Systems
Jan 6, 2021 17:17 HKT/SGT
Hitachi Automotive Systems, Keihin, Showa, and Nissin Kogyo Conclude Management Integration and Commence Operations as Hitachi Astemo
Dec 28, 2020 08:19 HKT/SGT
Hitachi Capital, Hitachi Asia, and SANTEC Begin Collaboration to Drive Solar Power Generation Business in Thailand
Dec 18, 2020 14:09 HKT/SGT
Hitachi Automotive Systems Stereo Camera with Lane Keep Assist Adopted by Suzuki for their 'XBEE' with Enhanced Safety Devices
Dec 17, 2020 15:04 HKT/SGT
Hitachi ABB Power Grids launches all-new remote terminal unit to support grid modernization and renewables integration
Dec 17, 2020 12:36 HKT/SGT
Arcelik and Hitachi Global Life Solutions Announce their Intention to Form a Joint Venture in the Global Home Appliances Business (excluding Japan)
Dec 10, 2020 08:14 HKT/SGT
Hitachi ABB Power Grids Energizes NordLink and Accelerates Europe Towards a Carbon-neutral Energy System
Dec 7, 2020 06:29 HKT/SGT
Hitachi ABB Power Grids' Innovative Technology Sset to Contribute to the UK's Carbon-neutral Future
Nov 13, 2020 09:13 HKT/SGT
Hitachi Develops IoT Platform for the High Value-added Buildings Required for the New Normal
More news >>
 News Alerts
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6859 8575

Connect With us: